Calder Biosciences is a startup based in the United States, most recent round Pre-Seed.
Calder Biosciences is a startup based in the United States. Its most recent tracked round is Pre-Seed.
Calder Biosciences is a molecular engineering company developing novel vaccines using a proprietary technology that stabilizes viral proteins to elicit strong immune responses against RSV, influenza, and other viral infections.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.